Oded Ben David

Oded Ben David has a diverse work experience, starting with their role as Director of M&A & Business Development at Ontada from December 2022. Prior to this, they worked as an Associate Director of Business Development at ImmunoGen, Inc. from October 2021 to December 2022.

Oded also served at Waters Corporation, first as a Transformation Lead from November 2020 to August 2021, and then as a Manager of the Corporate Development Office (M&A) from July 2019 to November 2020.

Before joining Waters Corporation, Oded worked at Genentech as an Associate in the Pipeline Strategy & Commercialization department in 2018. During their time there, they initiated novel co-commercialization strategies and was admitted to The Roche Business Perspectives Program.

Prior to their industry experience, Oded worked at TASC Consulting & Capital in various roles in the healthcare practice from 2013 to 2017. Oded held positions as an Engagement Manager, Consultant, and Business Analyst.

Oded's early career includes serving in the Israel Defense Forces, where they held the role of Captain and Head of Strategy in Unit 269 (Special Reconnaissance), the Intelligence Arm, from November 2005 to January 2010.

Oded Ben David has a Master of Business Administration (MBA) degree in Business Administration and Management, General from Harvard Business School. Prior to their MBA, Oded earned a Bachelor's degree in Economics and Management from Tel Aviv University.